Bayer Consumer Health Scales Global Self-Service Analytics with Databricks Unity Catalog
LEVERKUSEN, Germany — Bayer Consumer Health has deployed Databricks’ Unity Catalog to build a unified, governed data platform that enables thousands of global stakeholders to perform self-service analytics without data silos, the companies announced.
The initiative, detailed in a new Databricks case study and scheduled for presentation at the Data + AI Summit 2025, marks a significant step in Bayer’s group-wide data strategy. By centralizing previously fragmented systems onto the Databricks Data Intelligence Platform, Bayer Consumer Health — known for over-the-counter products such as Aspirin and Bepanthen — has created reusable core data assets that support cost-efficient dashboarding, ad hoc analytics, machine learning, and AI solutions.
Five years ago, Bayer faced the common challenge of fragmented systems and data silos that hindered timely decision-making across its global consumer health operations. The adoption of Databricks and Unity Catalog allowed the division to establish a single governed platform that maintains security and compliance while democratizing data access.
Unified Governance at Scale
Unity Catalog, Databricks’ unified governance solution for data and AI assets, serves as the backbone of Bayer’s new architecture. It provides centralized management of core data assets that are described as integrated and reusable, enabling consistent discovery, access, and collaboration across regions.
According to the Databricks blog post, the globally distributed platform empowers employees to generate insights independently while ensuring data quality, integration, analytics capabilities, and security — priorities outlined in Bayer’s broader data strategy.
Bayer has emphasized the critical role of high-quality data in powering AI initiatives. In a statement on its corporate site, the company noted: “The right data is critical to AI. Precise and effective insights and predictions can only be achieved with high-quality data that is accurate and complete.” Bayer developed its group-wide data strategy focusing on quality, integration, analytics, and security to position the organization for responsible AI use.
Supporting Precision Health and Self-Care Innovation
The project aligns with Bayer’s vision of advancing precision health alongside its traditional self-care portfolio. The company, a global leader in healthcare and nutrition, sees reliable data infrastructure as foundational to developing AI-driven solutions that help people live healthier lives.
The Databricks platform now supports a wide range of use cases across Bayer Consumer Health’s international operations. These include operational analytics for supply chain and commercial functions, as well as more advanced machine learning models that can inform product development and personalized consumer insights.
Industry Context
Bayer’s implementation reflects a growing trend among large life sciences and healthcare organizations to modernize data platforms using lakehouse architectures. Unity Catalog has become a key differentiator for Databricks in enterprise deployments, particularly in regulated industries that require strong governance over sensitive data assets.
The Bayer case study will be featured as part of Databricks’ Data + AI Summit 2025 healthcare and life sciences track, where the company plans to showcase how consumer health divisions can scale self-service analytics globally while maintaining enterprise-grade controls.
Impact on Developers, Analysts, and the Industry
For Bayer’s internal users, the platform significantly reduces dependency on centralized data teams. Analysts and business stakeholders can now discover, access, and analyze governed data assets independently, accelerating time-to-insight across global markets.
The approach also benefits data engineers and AI developers by providing standardized, reusable data products rather than ad hoc datasets, improving productivity and reducing duplication of effort. From an industry perspective, the deployment demonstrates how Unity Catalog can help large, geographically dispersed organizations balance self-service access with the strict governance requirements common in healthcare and life sciences.
What’s Next
Bayer Consumer Health plans to continue expanding its use of the Databricks platform, with further integration of advanced AI and machine learning capabilities expected in the coming months. The company will share additional technical details and lessons learned during its presentation at the Data + AI Summit 2025.
Databricks has not disclosed specific contract values or exact performance benchmarks for the Bayer deployment. The full case study is available on the Databricks website, with the summit session expected to provide deeper implementation insights for other enterprises in the sector.
This partnership underscores the increasing strategic importance of modern data platforms in enabling responsible, scalable AI adoption within traditional life sciences companies.